Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Latest
Valuentum Commentary
Aug 10, 2016
Oncology News a Key Driver of Big Pharma
Image Source: Images Money. Oncology product portfolios and pipelines have been key factors in the big pharma industry as of late. May 17, 2016
Big Pharma 1Q Earnings Roundup, Part II
Image Source: Paw Paw. Let’s take a look at the first quarter performance and some major news for some of the biggest players in the pharmaceuticals sector. Included in this article: ABBV, AGN, BMY, AMGN, MRK, PFE. May 13, 2016
Teva Bounces After Strong First Quarter
Image Source: Teva. Shares of Best Ideas Newsletter portfolio holding Teva Pharmaceuticals have experienced volatility in recent trading periods as the company continues to work towards finalizing its acquisition of Allergan’s generic drug portfolio and as market participants assess first quarter results. Feb 21, 2016
Growing Cautious on Teva Pharma
Best Ideas Newsletter portfolio holding Teva Pharmaceuticals reported a disappointing fourth quarter. Feb 12, 2016
Your Hard-Earned Money
Valuentum is releasing its February Best Ideas Newsletter early, February 12, in light of Presidents’ Day weekend. Dec 18, 2015
Analysis: The Best Ideas Portfolio
The Best Ideas Newsletter portfolio is one of the most followed newsletter portfolios among our membership. In the spirit of transparency, let’s examine the portfolio’s returns from a variety of different perspectives. The Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio are not real money portfolios. Results are hypothetical and do not represent actual trading. Past results are not a guarantee of future performance. Dec 6, 2015
Leading Investors to Water…
…did they drink? Let’s examine the performance of Valuentum’s best ideas in 2015. Nov 5, 2015
Catching Up With Some of Our Best Ideas
Let’s take a look at the recent performance of a few companies within the Best Ideas Newsletter portfolio. Oct 28, 2015
Around the Horn in Biotech/Pharma: 3Q Earnings Review
Abbott, Biogen, Bristol-Myers, Eli Lilly, Gilead, GlaxoSmithKline, Merck, Pfizer… Sep 25, 2015
Recent M&A Activity
Let’s take a look at some recent M&A activity across the market. Latest News and Media The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
